What is BioSense Global?
BioSense Global, operating under the brand Audrey Laurelton RDN, is a health and wellness enterprise committed to fostering healthy lifestyles through science-backed resources. The company provides a comprehensive suite of offerings, including meticulously tested recipes, informative articles, and tailored wellness programs designed to guide individuals and families toward their health objectives while promoting environmental consciousness. Services such as private counseling and nutrigenomics testing are available to support clients in their pursuit of enhanced well-being. BioSense Global emphasizes practical, evidence-based methodologies to cultivate sustainable and rewarding lifestyles.
How much funding has BioSense Global raised?
BioSense Global has raised a total of $35K across 1 funding round:
Debt
$35K
Debt (2021): $35K with participation from PPP
Key Investors in BioSense Global
PPP
Public-Private Partnership
What's next for BioSense Global?
With the recent influx of substantial expansion capital, BioSense Global is strategically positioned to scale its operations and broaden its market reach. The company is expected to leverage this investment to enhance its digital platform, expand its service offerings, and potentially explore new market segments within the burgeoning health-tech and personalized wellness industries. Future developments may include advancements in its nutrigenomics testing capabilities and the expansion of its personalized counseling services, further solidifying its role as a leader in science-driven wellness.
See full BioSense Global company page
